Takeda Rises as Diabetes-Drug Verdict Thrown Out in U.S.

Takeda Pharmaceutical Co. persuaded a judge to throw out a $6.5 million jury verdict over its Actos diabetes drug because lawyers for a California man didn’t produce sufficient evidence to show his cancer was caused by the medication. The company’s shares rose.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.